Aerovate Therapeutics, Inc.
AVTE
$2.66
$0.083.10%
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Net Income | -5.43M | -16.24M | -24.78M | -23.19M | -20.41M |
| Total Depreciation and Amortization | 8.00K | 218.00K | 28.00K | 28.00K | 28.00K |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 1.16M | 1.54M | 3.17M | 3.44M | 2.31M |
| Change in Net Operating Assets | -6.79M | -1.57M | 1.14M | -3.96M | 3.27M |
| Cash from Operations | -11.05M | -16.04M | -20.43M | -23.67M | -14.80M |
| Capital Expenditure | -- | -- | -- | -- | -64.00K |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 13.13M | 16.07M | 18.00M | 8.83M | 5.71M |
| Cash from Investing | 13.13M | 16.07M | 18.00M | 8.83M | 5.65M |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | 554.00K | 22.00K | 24.45M | 704.00K | 463.00K |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | 0.00 | 0.00 | -74.00K | -233.00K | 0.00 |
| Cash from Financing | 554.00K | 22.00K | 24.38M | 471.00K | 463.00K |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 2.64M | 46.00K | 21.95M | -14.37M | -8.69M |
